Pten knockout affects drug resistance differently in melanoma and kidney cancer.

Klaudia K BrodaczewskaAleksandra MajewskaAleksandra Filipiak-DulibanClaudine Kieda

Published in: Pharmacological reports : PR (2023)

The results confirmed heterogenous cell responses to PTEN loss, which may lead to a better understanding of the role of PTEN in particular types of tumors and points to PTEN as a therapeutic target for personalized medicine.

Keyphrases

pi k akt
cell proliferation
signaling pathway
papillary thyroid
single cell
cell therapy